Universiti Kebangsaan Malaysia Medical Centre
Quick facts
Marketed products
- Dexamethasone, granisetron & palonosetron
- Latanoprost/Timolol · Ophthalmology
Latanoprost reduces intraocular pressure by increasing uveoscleral outflow of aqueous humor, while timolol decreases aqueous humor production via beta-adrenergic receptor antagonism.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Universiti Kebangsaan Malaysia Medical Centre portfolio CI brief
- Universiti Kebangsaan Malaysia Medical Centre pipeline updates RSS
Frequently asked questions about Universiti Kebangsaan Malaysia Medical Centre
What are Universiti Kebangsaan Malaysia Medical Centre's marketed drugs?
Top marketed products include Dexamethasone, granisetron & palonosetron, Latanoprost/Timolol.
Related
- Dexamethasone, granisetron & palonosetron
- Latanoprost/Timolol · Ophthalmology
- Sector hub: All tracked pharma companies